Hb Rancho Mirage [beta 143(H21)His----Asp]; a variant in the 2,3-DPG binding site showing normal oxygen affinity at physiological pH. 1992

W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
Centers for Disease Control, Atlanta, GA 30333.

Hb Rancho Mirage was detected in a 17-year-old male in association with a mild anemia. Hemoglobin electrophoresis revealed the variant had a mobility between Hbs A and J on cellulose acetate (pH 8.6) and a mobility like Hb F on citrate agar (pH 6.4). A substitution of His----Asp was found at position 143 in the beta chain, a residue that contributes to the anionic 2,3-DPG binding site in Hb. This variant exhibited normal oxygen affinity at physiologic pH and reduced affinity at alkaline pH. This suggested a subtle shift in the allosteric equilibrium due most likely to the introduction of a negative charge that stabilized the 2,3-DPG pocket. Both homotrophic (heme-heme) and heterotropic (2,3-DPG and protons) effects were reduced; this might be a consequence of an alteration in the carboxyl terminal region of the beta-subunits. Although a His----Asp substitution would be considered to cause reasonable disruption of the 2,3-DPG and C-terminal conformation of the beta- subunits, the properties of Hb Rancho Mirage suggest that, in fact, there appear to be no major perturbation of the critical C-terminal residues.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010449 Peptide Mapping Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases. Fingerprints, Peptide,Peptide Fingerprinting,Protein Fingerprinting,Fingerprints, Protein,Fingerprint, Peptide,Fingerprint, Protein,Fingerprinting, Peptide,Fingerprinting, Protein,Mapping, Peptide,Peptide Fingerprint,Peptide Fingerprints,Protein Fingerprint,Protein Fingerprints
D004163 Diphosphoglyceric Acids Glyceric acids where two of the hydroxyl groups have been replaced by phosphates. Bisphosphoglycerates,Acids, Diphosphoglyceric
D006455 Hemoglobins, Abnormal Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains. Abnormal Hemoglobins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
August 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
January 1987, Hemoglobin,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
January 1976, Acta haematologica,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
June 1993, Hemoglobin,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
January 1990, Hemoglobin,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
January 1989, Hemoglobin,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
January 1990, Hemoglobin,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
January 1998, Hemoglobin,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
January 1994, Hemoglobin,
W F Moo-Penn, and T K Hine, and M H Johnson, and D L Jue, and S Holland, and S George, and A M Pierce, and L A Michalski, and M J McDonald
January 2009, Hemoglobin,
Copied contents to your clipboard!